Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 2Phase 3 1

Status

Recruiting 10Unknown 7Not yet recruiting 5Terminated 4Completed 3Active not recruiting 3Withdrawn 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Carcinoma, Non-Small-Cell Lung 4Lung Neoplasms 1

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 142Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Terminated × Platinum Compounds × Clear all
NCT04966676 2026-01-08

ATLAS

University Health Network, Toronto

Phase 2 Terminated
5 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04765709 2025-12-16

BRIDGE

Mario Negri Institute for Pharmacological Research

Phase 2 Terminated
10 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00404703 2016-08-24

A Study of Avastin (Bevacizumab) in Combination With Platinum-Based Chemotherapy in Patients With Advanced or Recurrent Squamous Non-Small Cell Lung Cancer

Hoffmann-La Roche

Phase 2 Terminated
37 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00391586 2015-08-17

Erlotinib and Standard Platinum-Based Chemotherapy for Newly Diagnosed, Advanced Non-Small Cell Carcinoma of the Lung

New Mexico Cancer Research Alliance

Phase 2 Terminated
45 enrolled 4 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡